• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 7, Issue 9
  3. Author

Online ISSN: 2515-8260

Volume7, Issue9

The Correlation Between Anti-Gliadin And Anti-Tissue Transglutaminase Autoantibodies With Gender In Iraq Celiac Disease Patients

    Lara Ghali A. Ali

European Journal of Molecular & Clinical Medicine, 2020, Volume 7, Issue 9, Pages 464-470

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

For finding or inquiring the efficiency of measuring the concentrations of IgG and IgA anti-gliadin autoantibodies (IgG and IgA AGA, respectively), IgA and IgG anti-transglutaminase (TGA), for gluten sensitivity diagnosis and study the relationship between those antibodies with age and gender of patients. The number of coeliac patients that enrolled in current study was 169. Concentrations of IgA, IgG for AGA as well as IgG, IgA for TgA was measured via enzyme-linked immunosorbent assay (ELISA). In the present study, the mean±SE of IgA antigliadin and IgA antitransglutaminase in age group 1-9 years was higher than 10-19 years without significance differences between them p>0.05, while the result show significant differences p<0.05 among age study groups in respect to IgG antiglidin and IgG transglutaminase since the mean of concentration in smaller ages was higher than older (10-19) years. In respect to gender, the females IgA antigliadin and tissue transglutaminase concentrations was higher than their concentrations in males with no significance differences detected between studied groups, while in other autoantibody tested, IgG antigladin and antitrasglutaminase concentrations there is significance differences between females and males with higher mean in females than males. According to the present study results, there are significant correlation between IgG antigliadin and anti-tissue transglutaminase with age and gender of celiac disease patients, since there concentration was higher in females younger than 10 years
Keywords:
  • PDF (127 K)
  • XML
(2020). The Correlation Between Anti-Gliadin And Anti-Tissue Transglutaminase Autoantibodies With Gender In Iraq Celiac Disease Patients. European Journal of Molecular & Clinical Medicine, 7(9), 464-470.
Lara Ghali A. Ali. "The Correlation Between Anti-Gliadin And Anti-Tissue Transglutaminase Autoantibodies With Gender In Iraq Celiac Disease Patients". European Journal of Molecular & Clinical Medicine, 7, 9, 2020, 464-470.
(2020). 'The Correlation Between Anti-Gliadin And Anti-Tissue Transglutaminase Autoantibodies With Gender In Iraq Celiac Disease Patients', European Journal of Molecular & Clinical Medicine, 7(9), pp. 464-470.
The Correlation Between Anti-Gliadin And Anti-Tissue Transglutaminase Autoantibodies With Gender In Iraq Celiac Disease Patients. European Journal of Molecular & Clinical Medicine, 2020; 7(9): 464-470.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 208
  • PDF Download: 270
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus